Posttranslational modifications of proteins, such as acetylation, are essential for the regulation of diverse physiological processes, including metabolism, development and aging. Autophagy is an evolutionarily conserved catabolic process that involves the highly regulated sequestration of intracytoplasmic contents in double-membrane vesicles called autophagosomes, which are subsequently degraded after fusing with lysosomes. The roles and mechanisms of acetylation in autophagy control have emerged only in the last few years. In this review, we describe key molecular mechanisms by which previously identified acetyltransferases and deacetylases regulate autophagy. We highlight how p300 acetyltransferase controls mTORC1 activity to regulate autophagy under starvation and refeeding conditions in many cell types. Finally, we discuss how altered acetylation may impact various neurodegenerative diseases in which many of the causative proteins are autophagy substrates. These studies highlight some of the complexities that may need to be considered by anyone aiming to perturb acetylation under these conditions.
Neurodegeneration: Altered protein tagging impairs brain’s clean-up mechanisms
Modulation of a chemical tagging process known as acetylation could help brain cells remove toxic proteins associated with Alzheimer’s disease, amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. David Rubinsztein and colleagues from the University of Cambridge, UK, review how enzymes that add or remove acetyl groups to or from proteins help to regulate autophagy, the process whereby damaged cellular components are removed. In neurons, imbalanced acetylation can result in the toxic build-up of proteins such as tau (Alzheimer’s disease), alpha-synuclein (Parkinson’s disease), huntingtin (Huntington’s disease) and superoxide dismutase 1 (ALS). The ensuing protein aggregation can then trigger progressive neuron loss and impaired function, especially as the brain ages. The authors propose that therapeutic targeting of acetylation to restore healthy autophagic activity could therefore have neuroprotective effects in many of these diseases.
Alzheimer’ Research UK (ARUK)https://doi.org/10.13039/501100002283n/aRubinszteinDavid C.UK Dementia Research Institute (funded by the MRC, Alzheimer’s Research UK and the Alzheimer’s Society) Cambridge Centre for Parkinson-Plus National Institute for Health Research Cambridge Biomedical Research Centrepublisher-imprint-nameSpringer Naturevolume-issue-count12issue-article-count13issue-toc-levels0issue-pricelist-year2021issue-copyright-holderThe Author(s)issue-copyright-year2021article-contains-esmNoarticle-numbering-styleUnnumberedarticle-registration-date-year2021article-registration-date-month1article-registration-date-day7article-toc-levels0toc-levels0volume-typeRegularjournal-productNonStandardArchiveJournalnumbering-styleUnnumberedarticle-grants-typeOpenChoicemetadata-grantOpenAccessabstract-grantOpenAccessbodypdf-grantOpenAccessbodyhtml-grantOpenAccessbibliography-grantOpenAccessesm-grantOpenAccessonline-firstfalsepdf-file-referenceBodyRef/PDF/12276_2021_Article_556.pdfpdf-typeTypesettarget-typeOnlinePDFissue-online-date-year2021issue-online-date-month2issue-online-date-day3issue-typeRegulararticle-typeReviewPaperjournal-subject-primaryBiomedicinejournal-subject-secondaryBiomedicine, generaljournal-subject-secondaryMolecular Medicinejournal-subject-secondaryMedical Biochemistryjournal-subject-secondaryStem Cellsjournal-subject-collectionBiomedical and Life Sciencesopen-accesstrue
These authors contributed equally: Sung Min Son, So Jung Park, Marian Fernandez-Estevez
Introduction
Macroautophagy (hereafter autophagy) is a process mediating the delivery of cytoplasmic components to the lysosome for degradation via double-membrane vesicles called autophagosomes1. In mammalian cells, autophagosomes are formed from cup-shaped precursor structures called phagophores, which include a complex of autophagy proteins, including ATG5, ATG12 and ATG16L12. The membranes of phagophores expand and form enclosed autophagosomes, and completed autophagosomes subsequently fuse with lysosomes2,3. Lysosomal digestion of autophagic cargoes protects cells against starvation and related stresses by releasing recycled building blocks from autophagic substrates.
Acetylation is a major posttranslational modification (PTM) and affects diverse aspects of protein function by altering properties such as stability, hydrophobicity, enzymatic activity, subcellular localization and interactions with other substrates and cofactors in the cell4. In acetylation, the acetyl group of an acetyl-coenzyme (Ac-CoA) can be co- or posttranslationally transferred to either the α-amino group of the N-terminus of a protein (Nt-acetylation) or to the ε-amino group of a lysine residue (K-acetylation). Nt-acetylation is catalyzed by highly conserved Nt-acetyltransferases (NATs) and is considered irreversible. On the other hand, K-acetylation is a reversible modification mediated by lysine acetyltransferases (KATs) at the ε-amino group of lysine residues. The tight regulation of acetylation by these enzymes plays fundamental regulatory roles in development and diverse human diseases, including diabetes and neurodegenerative conditions4.
In this review, we describe how autophagy is regulated by acetylation, particularly K-acetylation, by previously identified KATs and deacetylases (KDACs). We also summarize the therapeutic targeting of acetylation, which may potentially lead to effective strategies to treat neurodegenerative diseases.
Introduction to autophagy
Under normal conditions, cells sustain basal levels of autophagy to maintain homeostasis. However, a variety of stimuli, including nutrient deprivation, metabolic imbalance or cellular stress, can activate autophagy2,3. Autophagosome biogenesis includes three early stages: initiation, nucleation, and expansion of the isolation membrane (Fig. 1), and the process is mediated by autophagy-related proteins (ATGs)2, which were initially discovered in yeast5. Many ATG proteins can be regulated by PTMs, such as phosphorylation, ubiquitination and acetylation6. The Unc-51-like autophagy-activating kinase (ULK) 1/2 complex (consisting of ULK1, ATG13, RB1-inducible coiled-coil protein 1 (FIP200) and ATG101) plays a major role in autophagy as a signaling node for several pathways and by phosphorylating downstream effectors. During the initiation of autophagosome formation, this complex acts as a serine/threonine kinase that phosphorylates Beclin 1 in the vacuolar protein-sorting 34/PI3-kinase (VPS34)/PI3K complex7. Additionally, the ULK1 complex recruits ATG9, which is thought to be involved in delivering membranes to autophagosomal structures and may act as a lipid scramblase8–10. The VPS34/PI3K complex generates phosphatidylinositol 3-phosphate (PI3P), which facilitates the recruitment of WD-repeat protein-interacting with phosphoinositides (WIPI2) that recruits the ATG5-ATG12-ATG16L1 complex to the sites of phagophore formation11. This complex enables the conjugation of LC3 and its family members to phosphatidylethanolamine in phagophore membranes12. To degrade the autophagosomal content, autophagosomes must fuse with a functional lysosome, and SNARE proteins mediate this fusion13.
Overview of the autophagy pathway.
mTORC1 inhibition and AMPK activation positively regulate the ULK1 complex through a series of phosphorylation events. The ULK1 complex subsequently activates VPS34/PI3K complexes, which leads to PI3P synthesis and the nucleation of preautophagosomal structures. PI3P then recruits PI3P effector proteins, namely, WIPIs and the ATG12-ATG5-ATG16L1 complex, which is essential for autophagosome membrane elongation. Subsequent fusion to lysosomes results in the degradation of a variety of substrates, such as protein aggregates, infectious agents, and damaged mitochondria.
Autophagy is tightly regulated by intracellular and extracellular signals14. Mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) integrates signals related to growth and metabolism in response to nutrient and energy levels and negatively regulates autophagy15 through the hosphorylation of ULK1, ATG13, transcription factor EB (TFEB) and other autophagy-related proteins under nutrient-rich conditions.
Regulation of acetylation in cellsNt-acetylation
Six different NATs have been identified in mammals (NatA to NatF)16. NATs regulate the transfer of an acetyl group from Ac-CoA to the free α-amino group of a polypeptide chain that is being synthesized. NATs can differ in their subunit composition and substrate specificity17. Nt-acetylation can regulate the subcellular localization of proteins, protein stability, and protein-protein interactions4.
K-acetylation
Lysine (K) acetylation depends on the use of Ac-CoA, and also nicotine adenine dinucleotide (NAD+) in the case of sirtuins, a class of lysine deacetylases (KDACs; HDACs), which use it as a co-substrate. This type of acetylation links metabolism with cell signaling, as Ac-CoA and NAD+ are key metabolites18, and modifies pathways that can be reversibly altered by deacetylases (Fig. 2). The K-acetylation and deacetylation of proteins were first studied in histones because of their roles in gene regulation. However, KATs and KDACs also acetylate nonhistone proteins in the nucleus or cytoplasm to regulate major biological processes19. Acetylation also occurs through nonenzymatic mechanisms and is affected by the availability of Ac-CoA20,21.
Regulation of lysine acetylation.
a Lysine acetylation is a reversible posttranslational modification of proteins, including histones. Proteins can be acetylated at lysine residues (Ac-K) by specific enzymes, i.e., KATs, or deacetylated by KDACs. b Most canonical mammalian KATs are classified into three major families: The p300/CBP, GNAT and MYST family. KDACs are divided into two categories: classical Zn2+ -dependent HDACs and NAD+ -dependent sirtuin deacetylases. KDACs can be further grouped into class I, class IIa, class IIb, class III and class IV.
KATs and KDACs and autophagy regulation
To date, approximately 40 mammalian proteins have been proposed to possess endogenous KAT activity. Thirteen are well characterized (canonical) and can be classified into three major families: the GCN5 (also known as KAT2A) and PCAF (also known as KAT2B) family (together members of the overarching GNAT family); the E1A binding protein p300 (encoded by EP300, also known as KAT3B) and CREB-binding protein (CBP, also known as KAT3A) family; and the MYST family, named for its founding members MOZ (also known as KAT6A), yeast Ybf2, Sas2, and Tip6 (also known as KAT5)22 (Fig. 2). All canonical KATs are predominantly localized in the nucleus and acetylate histones and nonhistone proteins. However, some KATs, such as p300, are nuclear but can be exported to the cytoplasm depending on intracellular signaling23. The substrate specificities of KATs are thought to be defined by their specific subcellular localization, their interacting proteins and the accessibility of lysine residues in substrate proteins19. KATs are found in unique complexes that influence their target specificities and their abilities to interact with other proteins22. More than 2,000 acetylation targets in the nucleus, cytoplasm, mitochondria and endoplasmic reticulum have been identified in human cells24.
The human genome encodes 18 KDACs, and they are divided into two major categories: zinc-dependent KDACs and NAD + -dependent sirtuin deacetylases (Table 1). On the basis of phylogenetic conservation and sequence similarities, zinc-dependent KDACs are further divided into four classes: class I, class IIa, class IIb and class IV25. Class I and class IV KDACs are localized in the nucleus, class IIb KDACs are cytoplasmic, and class IIa KDACs are primarily localized in the nucleus but are also found in the cytoplasm. Sirtuin (SIRT) deacetylases localize to different cellular compartments26, including the nucleus (SIRT1, SIRT6 and SIRT7), cytoplasm (SIRT2) and mitochondria (SIRT3, SIRT4 and SIRT5).
KATs and KDACs on regulation of autophagy.
Class
Representatives
Effect on autophagy
Main subcellular location
Ref.
KATs
p300/CBP family
CBP/KAT3A
Induction
Nucleus
27
Inhibition
Nucleus
30
p300/KAT3B
Inhibition
Nucleus
28–30
GNAT family
GCN5/KAT2A
Inhibition
Nucleus
31
PCAF/KAT2B
Induction
Nucleus
32
HAT1/KAT1
Not reported
Nucleus
—
MYST family
TIP60/KAT5
Induction
Nucleus
33
MOZ/KAT6A
Not reported
Nucleus
—
MORF/KAT6B
Not reported
Nucleus
—
HBO1/KAT7
Not reported
Nucleus
—
MOF/KAT8
Inhibition
Nucleus
34
KDACs
Class I
HDAC1
No effect
Nucleus
37,38
Inhibition
35,36
HDAC2
Induction
Nucleus
37
HDAC3
Inhibition
Nucleus
27
HDAC8
Inhibition
Nucleus
42
Class IIa
HDAC4
Inhibition
Nucleus
39,40
HDAC5
Inhibition
Nucleus
40
HDAC7
Inhibition
Nucleus
41
HDAC9
Inhibition
Nucleus
43
Class IIb
HDAC6
Induction
Cytoplasm
44–47
HDAC10
Induction
Cytoplasm
48
Class IV
HDAC11
Not reported
Nucleus
—
Class III (Sirtuins)
SIRT1
Induction
Nucleus
49,50
SIRT2
Inhibition
Cytoplasm
51
SIRT3
Induction
Mitochondria
52
SIRT4
Induction
Mitochondria
55
SIRT5
Induction
Mitochondria
53
SIRT6
Induction
Nucleus
54
SIRT7
Induction
Cytoplasm
56
In mammalian cells, KATs and KDACs play pivotal roles in autophagy regulation at multiple steps27 (Table 1). As protein acetylation is a major regulator of gene transcription, the epigenetic regulation of autophagy genes by KATs or KDACs may be important for autophagy regulation. Depending on the target proteins of KATs and KDACs, acetylation has the potential to induce or inhibit autophagy (Table 1).
Regulation of autophagy by p300-dependent acetylation
Among KATs, p300 appears to acetylate many ATG proteins that regulate autophagy at multiple steps27–29 (Table 1). p300 depletion or specific p300 inhibitors can induce autophagy, whereas the overexpression of p300 inhibits autophagy28,29.
Recently, we reported that under nutrient-depleted conditions, such as amino acid (AA) or leucine starvation, p300-dependent acetylation regulates autophagy through the acetylation of the mTORC1 component Raptor at K109730. This acetylation of Raptor enables the interaction of mTORC1 with the Rag complex on the lysosomal membrane, where mTORC1 is activated. In this way, Raptor acetylation is mediated by leucine, and p300 activation results in mTORC1 activation and autophagy repression. Cells expressing an acetylation-dead mutant of Raptor (Raptor K1097R; KR) manifested autophagy activation without altered acetylation of autophagy-related proteins. Furthermore, p300 activation had no discernible effects on autophagy levels in Raptor KR-expressing cells or in cells where mTORC1 was inhibited. Thus, our data suggest that p300 activity (and leucine) inhibits autophagy primarily by activating mTORC1 rather than by altering the acetylation of other proteins30. This Ac-CoA-p300-Raptor regulation of autophagy via mTORC1 occurs in most cell types, including neurons (Fig. 3).
Regulation of autophagy by p300-dependent acetylation.
Ac-CoA activates p300, which acetylates Raptor, leading to mTORC1 activation, which inhibits autophagy. Under nutrient (e.g., leucine) deprivation conditions, autophagy activation is mainly mediated by decreased Raptor acetylation to inhibit mTORC1.
The regulation of autophagy by other KATs
GNAT family
In mammalian cells and Drosophila, GCN5 inhibits the biogenesis of autophagosomes and lysosomes by regulating the acetylation of TFEB at lysine 274 and lysine 279. The acetylation of TFEB disturbs its dimerization and its subsequent binding to target gene promoters, many of which regulate autophagy or lysosomal biogenesis31. PCAF, another member of the GNAT family, is reported to regulate autophagy through the inhibition of the mTORC1 pathway in some cancers, such as hepatocellular carcinoma32.
MYST family
The MYST acetyltransferase family also appears to regulate autophagy. Serum deprivation leads to the association of the protein kinase GSK3β with TIP60/KAT5 and subsequent phosphorylation at serine 86 of TIP60. Phosphorylated TIP60 acetylates and activates ULK133, which is essential for serum deprivation-induced autophagy. Additionally, under nutrient starvation, the induction of autophagy is coupled to a reduction in histone H4 lysine 16 (H4K16) acetylation through the downregulation of MOF/KAT834.
The regulation of autophagy by KDACs
KDACs family
KDAC family members are important for the regulation of autophagy at several levels. HDAC1 has been reported to be overexpressed in hepatocellular carcinoma, and inhibition of HDAC1 induces autophagy to repress tumor cell growth35. Chemical or genetic HDAC1 inhibition also induces autophagy and lysosomal activity in HeLa cells36. However, knocking down HDAC2, but not HDAC1, inhibited autophagy in cardiomyocytes37. In contrast, the deletion of both HDAC1 and HDAC2 in mice blocked autophagic flux in skeletal muscle38. Knocking down class IIa HDAC4 leads to autophagy induction by increasing the expression levels of ATG proteins, including Beclin 1 and ATG739.
MicroRNA-dependent protein acetylation can also regulate autophagy. The regulation of HDAC4 and HDAC5 by miRNA-9 increased total LC3B and Rab7 levels40. Another study showed that the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) decreased HDAC7 protein levels in endometrial stromal sarcoma cells, producing an accumulation of autophagic vacuoles41. Recently, the HDAC8-selective inhibitor HMC was shown to induce autophagy in MCF-7 cells42. In response to hypoxia in a myoblast cell line, class IIa HDAC9 was significantly increased, thereby inhibiting intracellular autophagy through direct binding to the promoter regions of Beclin 1, ATG7 and LC343.
Class IIb HDAC6 is the only mammalian deacetylase that contains a ubiquitin-binding domain; therefore, when the ubiquitin-proteasome system is impaired, this HDAC has an important role in autophagy-dependent protein degradation44. Furthermore, HDAC6 overexpression increases autophagosome formation in various liver cancer cells by activating c‐Jun NH2‐terminal kinase (JNK)45. Additionally, HDAC6 depletion impairs serum starvation-induced autophagy. In serum-starved cervical carcinoma cells, increased LC3 acetylation resulting from HDAC6 inhibition correlated with decreased autophagic flux46. HDAC6 is also important for autophagosome-lysosome fusion. HDAC6 knockout impaired the fusion of autophagosomes and lysosomes by perturbing the formation of F-actin networks mediated by acetylation of cortactin47. Another class IIb deacetylase, HDAC10, promotes autophagy in neuroblastoma cells, and its knockdown disrupts autophagic flux48. In most studies, depletion of class I and IIa HDACs is associated with the enhanced expression of autophagy regulators involved in the induction steps, which results in the upregulation of autophagy. By contrast, inhibition of class IIb HDACs, such as HDAC6 and HDAC10, is more associated with the blockade of autophagic flux.
Sirtuins
The sirtuin family of class III HDACs are NAD + -dependent deacetylases that modulate a variety of cellular processes, including energy metabolism, stress responses, cell survival and proliferation. The deacetylation reactions catalyzed by sirtuins are coupled to the cleavage of NAD + into nicotinamide and 1-O-acetyl-ADP ribose. Therefore, sirtuin activities are dependent on the availability of cellular NAD + and are influenced by cellular metabolic status. Seven sirtuins (SIRT1 to SIRT7) have been identified in the human genome, and recent studies have proposed important roles for all sirtuins in the regulation of autophagy49–56. In particular, SIRT1 deacetylates ATG5, ATG7 and LC3 and appears to positively regulate autophagy at several steps49.
KATs and KDACs in neurodegenerative disease
Most of the neurodegenerative diseases in humans are caused by toxic intracytoplasmic, aggregate-prone proteins. Alzheimer’s disease (AD) pathology is characterized by amyloid-beta, an extracellular product derived from amyloid precursor protein (APP), and intracellular aggregated tau57. Parkinson’s disease (PD) is associated with the accumulation of alpha-synuclein (α-syn), and excess levels of this protein are sufficient to cause disease58. Huntington’s disease is a monogenic autosomal dominant disease caused by polyglutamine tract expansions in the huntingtin protein, while amyotrophic lateral sclerosis (ALS) can be either monogenic or complex. The monogenic causes of ALS include mutations in SOD1, FUS and TDP-4359. Importantly, all of these disease-causing intracytoplasmic proteins are autophagy substrates, and autophagy-upregulating drugs and genes enhance the clearance of these proteins and attenuate their toxicities in a range of animal models (flies, zebrafish and mice)60–69. Autophagy may also protect against neurodegeneration by dampening inflammatory-type processes and apoptosis70,71.
The importance of acetylation regulated by KATs and KDACs in neurodegenerative diseases has been highlighted by observations that imbalanced acetylation causes progressive neuron-specific loss, impaired neuronal function, and eventual neuronal death72. Many studies have reported that abnormal acetylation and deacetylation are linked to the pathogenesis of a variety of neurodegenerative diseases73 (Table 2). We briefly review the relationships between acetylation and different neurodegenerative diseases to reveal some of the complexities that may emerge when perturbing relevant modifying enzymes, as these may impact not only autophagy but also numerous other cellular processes pertinent to neurodegeneration.
Alzheimer’s disease (AD)
p300-mediated histone H3 acetylation at the presenilin 1 (PS1) and beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) promoters is upregulated, consequently enhancing the expression levels of these genes in an AD model cell line74. Interestingly, p300 levels are significantly increased in an AD model cell line, suggesting that p300 regulates the expression of AD-related genes by controlling acetylation or their promoters. The overexpression of CBP leads to recovered loss of learning and memory in AD triple transgenic mice75. On the other hand, acetylation of tau can be modulated by p300 and SIRT1, and excess acetylated tau may contribute to tau-mediated neurodegeneration76. Interestingly, hyperactivation of p300/CBP activity has been reported to disrupt autophagic flux and cause excessive tau secretion77. PCAF knockout mice are resistant to Aβ-induced toxicity and memory deficits, an effect that has been attributed to the upregulation of the activity of the Aβ-degrading enzyme Neprilysin78. Impaired function of TIP60 has been described in the human AD hippocampus, and imbalanced TIP60/HDAC2 activity is observed in the brain of an APP Drosophila AD model, suppressing the activities of neuroplasticity genes, which can be rescued by overexpression of TIP6079.
Inactivation of HDAC1 activity by the p25/Cdk5 complex, which is involved in neurodegenerative diseases, including AD, causes double-strand DNA breaks and neurotoxicity, which can be restored by HDAC1 overexpression80. Moreover, HDAC3 promotes tauopathy, whereas suppression of HDAC3 may affect not only nonamyloidogenic APP processing but also neuroprotective gene expression in vitro and in an AD mouse model81. Nuclear translocation of class II HDACs such as HDAC4 and HDAC6 is regulated by Aβ oligomers and the apolipoprotein E ε4 allele (apoE4), which is a critical AD risk factor, resulting in the downregulation of BDNF expression, which is important for controlling synaptic repair and synaptic plasticity82. HDAC6 binds to tau in the perinuclear aggresomal compartment, and HDAC6 levels are upregulated in the hippocampus of AD patients and AD mice83. By contrast, loss of HDAC6 improves learning and memory, α-tubulin acetylation and cognitive function in an AD mouse model84. In the brains of an AD mouse model, overexpression of SIRT1 inhibits Aβ oligomers and plaque burden and ameliorates behavioral deficits, suggesting a neuroprotective role for SIRT1 in AD85. Loss of SIRT2 induces microtubule stabilization and initiation of the subsequent autophagic-lysosomal pathway to degrade toxic Aβ oligomers in an AD-derived cell model85.
Parkinson’s disease (PD)
While α-syn is believed to be an important effector of PD because of its activities in the cytoplasm, α-syn may also mediate neurotoxicity by interacting with histone H3, thereby inhibiting histone acetylation by inactivating several KATs, including CBP, p300 and PCAF86. The suppression of SIRT2 by either siRNA or a potent inhibitor prevents α-syn-dependent neurotoxicity, as well as the formation of α-syn inclusions in vitro and in a Drosophila model of PD87. However, the relationship between SIRT2 inhibition and α-syn aggregation is still unclear. In cortical Lewy bodies, α-syn colocalizes with the microtubule-binding proteins MABP1 and tau. Increased acetylation of α-tubulin by the inhibition of SIRT2 may promote the formation of α-syn aggregates by binding to microtubules, suggesting that stabilized microtubules can play an important role in neuroprotection87. Furthermore, the upregulation of SIRT2 prevents microtubule hyperacetylation and axonal degeneration88. The overexpression of SIRT1 increases the lifespan of an α-syn A53T PD mouse model and prevents the formation of α-syn aggregates. SIRT1 deacetylates HSF1 (heat shock factor 1) and thereby increases Hsp70 levels, suggesting that Hsp70 activation can inhibit the α-syn-mediated neurotoxicity of Hsp7089.
Huntington’s disease (HD)
CBP is observed in the aggregates formed by mutant huntingtin (mHtt)90. PolyQ expansions, the mutations in the huntingtin protein, directly interact with and sequester CBP and PCAF in animal models, leading to transcriptional dysregulation91. In addition, loss of CBP from the nucleus impairs HAT activity and CBP-mediated gene expression, resulting in neuronal dysfunction and neuronal death92,93. Furthermore, soluble mHtt may enhance ubiquitination to accelerate CBP degradation via the ubiquitin-proteasome system94. mHtt acetylation at lysine 444 (K444) by CBP activation or HDAC1 inhibition promotes its trafficking to autophagosomes and subsequent clearance in primary neurons and a C. elegans HD model, suggesting a role in neuroprotection95. Similarly, HDAC6-mediated retrograde transport on microtubules may facilitate mHtt degradation through autophagy44. Several studies have reported that SIRT1 activity ameliorates mHtt-mediated toxicity in both cellular and animal models. In addition, mHtt suppresses SIRT1 deacetylase activity through a direct interaction causing SIRT1 to remain hyperacetylated, leading to the attenuation of SIRT1-regulated neuroprotective effects96. However, SIRT2 controls HD-related metabolism, such as cholesterol biosynthesis, leading to increased production of cholesterol, further increasing mHtt aggregation97.
Amyotrophic lateral sclerosis (ALS)
Transgenic mice expressing the disease-causing mutant protein SOD1 G86D have low levels of histone H3 acetylation and CBP in motor neurons98. Similar to SOD ALS mouse models, low levels of CBP are found in the motor neurons of sporadic ALS patients99. Furthermore, SOD1 mutants may cause disrupted axonal transport and contribute to the loss of mitochondria from axons because of defective microtubule-dependent trafficking100. Interestingly, decreased acetylation of α-tubulin is observed in HAT Elp3-deficient cortical neurons101. Knocking out HDAC6 in SOD1 G93A-expressing mice reduces motor neuron degeneration and increases acetylated α-tubulin without affecting disease onset102. However, conflicting functions of HDAC6 in mice harboring mutant SOD1 have also been reported. Inhibition of HDAC6 promotes the formation of large mutant SOD1 aggregates, which is accompanied by the increased acetylation of α-tubulin and enhanced microtubule retrograde transport. Interestingly, HDAC6 specifically binds to mutant SOD1 through SOD1 mutant interaction region (SMIR) motifs103. Other ALS-causing proteins, namely, TDP-43 and FUS/TLS, appear to interact with HDAC6 to control mRNA expression levels. Moreover, the downregulation of TDP-43 lowers the levels of HDAC6, leading to disrupted aggregate formation104. G93A SOD1 induces DNA damage and subsequently facilitates apoptosis by activating p53105. p53 K320 acetylation is modulated by p300/CBP and PCAF and produces neuroprotective effects, including neurite outgrowth and axon regeneration106. Furthermore, p53 K382 acetylation is controlled by p300/CBP and SIRT1, thereby facilitating neuronal apoptosis106.
KAT and KDAC enzymes and neurodegenerative diseases.
Disease
Class
Prognostic relevance
Molecular evidence
Molecular consequence
Opposite effect
Ref.
AD
KAT
p300
Upregulated in N2a/APPswe cells
Binding to the PS1 and BACE1 promoters and acetylation
p300 increases PS1 and BACE1 expression levels and increases the expression of Aβ.
Overexpression of p300 induces neuronal cell death linked to AD pathology.
74
Increased p-p300 (Ser1834) in CA1 of AD brain
p-p300-positive neurons colocalize with p-tau
p300 leads to tauopathy.
107
Decreased in AD brain
Aβ induces posttranslational degradation of p300.
108
CBP
Decreased in AD brain
Overexpression of CBP rescues learning and memory loss in AD mice.
75,108
PCAF
Decreased in AD brain
Regulation of NEP and low level of SRIH
Knocking out PCAF reduces Aβ-mediated toxicity.
78,108
TIP60
Human AD hippocampus, APP Drosophila
Suppression of synaptic plasticity gene
TIP60 suppresses synaptic plasticity.
79
Drosophila CNS
Binding to APP through AICD
Tip60 functions neuroprotection.
109
KDAC
HDAC1
Decreased in frontal cortex and hippocampal region of AD patients
Inactivation by the p25/Cdk5 complex
Inactivated HDAC1 causes dsDNA breaks and neurotoxicity.
Overexpression of HDAC1 leads to neuroprotection.
80,108
HDAC2
Upregulated in AD brain
Inhibition of neuronal gene expression
HDAC2 causes disruption of synaptic plasticity and neuronal development.
HDAC2 deficiency improves the increased synapse numbers and memory.
110
HDAC3
In vitro and AD mice model
HDAC triggers not only tau phosphorylation but also Aβ metabolism in AD cellular and animal models.
Inhibition of HDAC3 decrease tau phosphorylation and Aβproduction, leading to a neuroprotective effect.
81
HDAC4/HDAC6
Increased nuclear localization
Nuclear localization by Aβ oligomers and ApoE4
HDAC4/6 affect inhibition of BDNF expression, which controls synaptic repair and plasticity.
82
HDAC6
Upregulated in AD patient, mice model and during AD progression
Binding to tau in perinuclear aggresome, deacetylation α-tubulin and tau.
HDAC6 leads to tauopathy.
Knocking down HDAC6 improves learning and enhanced memory in AD mice.
83,84,111
SIRT1
Decreased in AD brain
Binding to tau
Loss of SIRT1 promotes p-tau and consequent tauopathy.
Overexpression of SIRT1 prevents tauopathy.
112
Reduced level of SIRT1 induces Aβ oligomers.
Upregulation of SIRT1 suppresses Aβ production through control of γ-secretase activity.
85,112
SIRT2
AD-derived cell model
Inhibition of microtubule stabilization
Loss of SIRT2 induces microtubule stabilization and degrades toxic Aβ oligomers by autophagy.
85
HD
KAT
CBP
Decreased in the hippocampus of mutant HdhQ7/Q111 mice
Reduced level of CBP impairs memory and induces neuron death.
113
Low expression of CBP in HD
Binding to polyQ expansions
Low level of CBP reduces acetyltransferase activity, leading to mHtt accumulation and impaired intracellular trafficking.
CBP overexpression promotes increased acetylation and degradation of mutant Htt.
95
Loss of CBP in HD Drosophila model and primary neurons
Acetylation of mHtt at K444
CBP-mediated mHtt acetylation at K444 triggers trafficking to autophagosome for mHtt degradation by autophagy.
95
PCAF
Loss of PCAF in HD Drosophila model
Binding to mHtt
Reduced PCAF level triggers neurodegeneration.
114
KDAC
HDAC6
SBMA Drosophila model
HDAC6 regulates mHtt degradation via autophagy.
115
SIRT1
Controls BDNF expression and mTORC1- CREB-regulated transcription
SIRT1 inhibits mHTT–mediated interference with mTORC1 activity and improves mHtt toxicity.
116
SIRT2
SIRT2 inhibition offers neuroprotection by decreasing sterol biosynthesis.
117
PD
KAT
CBP, p300, PCAF
Inhibition of CBP, p300 and PCAF induce histone H3 deacetylation
86
KDAC
SIRT1
Downregulated in PD brain
Extension of the life span of αSyn A53T-expressing mice
SIRT1 prevents the formation of αSyn aggregates.
89
Deacetylation of HSF1 and increase in Hsp70
SIRT1 Inhibits αSyn-mediated neurotoxicity by activating molecular chaperones.
89
SIRT2
Upregulated in PD
Binding to α-tubulin
SIRT2 inhibits α-tubulin hyperacetylation and leads to axonal degeneration.
Inhibition of SIRT2 promotes αSyn mediated neurotoxicity through α tubulin acetylation.
87,88
ALS
KAT
CBP
Low level of CBP in motor neuron of ALS patients
99
P300, CBP, PCAF
Acetylation of p53 K320
Neuroprotection
106
P300, CBP
Acetylation of p53 K382
Neuronal apoptosis
106
KDAC
HDAC2
Upregulated mRNA
118
HDAC11
Downregulated mRNA
118
HDAC6
Downregulated in TDP-43 and FUS/ALS
Binding to SOD mutants
Disrupted aggregation formation
Knockout of HDAC6 prevents motor neuron degeneration in SOD G93A mice.
102,119
Concluding remarks
Although the mechanisms remain incompletely understood, accumulating evidence indicates that different KATs and KDACs play pivotal roles in autophagy regulation at multiple steps of the pathway. New links between protein acetylation and autophagy control are likely to emerge. Acetylation also plays a crucial regulatory role in pathological conditions, particularly in neurodegenerative diseases and cancer. Thus, identifying how acetylation impacts various processes involved in neurodegenerative diseases, including autophagy, will help to inform suitable therapeutic strategies.
Acknowledgements
We are grateful for funding from the UK Dementia Research Institute (funded by the MRC, Alzheimer’s Research UK and the Alzheimer’s Society), Roger de Spoelberch Foundation, Alzheimer’s Research UK, Cambridge Centre for Parkinson-Plus, National Institute for Health Research Cambridge Biomedical Research Centre (D.C.R.). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
Conflict of interest
D.C.R. is a consultant for Aladdin Healthcare Technologies, Nido Biosciences and Drishti Discoveries. The remaining authors declare no competing interests.
ReferencesMizushimaNKomatsuMAutophagy: renovation of cells and tissues20111477287411:CAS:528:DC%2BC3MXhsVKgsLnN10.1016/j.cell.2011.10.026BentoCFMammalian autophagy: how does it work?2016856857131:CAS:528:DC%2BC28XisVGitL0%3D2686553210.1146/annurev-biochem-060815-014556StamatakouEMendelian neurodegenerative disease genes involved in autophagy20206241:CAS:528:DC%2BB3cXosV2jsb0%3D32377374719861910.1038/s41421-020-0158-yDrazicAMyklebustLMReeRArnesenTThe world of protein acetylation20161864137214011:CAS:528:DC%2BC28XpvFShsL0%3D2729653010.1016/j.bbapap.2016.06.007TsukadaMOhsumiYIsolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae19933331691741:CAS:528:DyaK3sXms1Kht7w%3D822416010.1016/0014-5793(93)80398-EKlionskyDJA comprehensive glossary of autophagy-related molecules and processes (2nd edition)201171273129421997368335948210.4161/auto.7.11.17661RussellRCULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase2013157417501:CAS:528:DC%2BC3sXnvVSitb0%3D23685627388561110.1038/ncb2757Maeda, S. et al. Structure, lipid scrambling activity and role in autophagosome formation of ATG9A. Nat. Struct. Mol. Biol., https://doi.org/10.1038/s41594-020-00520-2 (2020).Matoba, K. et al. Atg9 is a lipid scramblase that mediates autophagosomal membrane expansion. Nat. Struct. Mol. Biol., https://doi.org/10.1038/s41594-020-00518-w (2020).KaranasiosEDynamic association of the ULK1 complex with omegasomes during autophagy induction2013126522452381:CAS:528:DC%2BC3sXhvFyntLfO2401354710.1242/jcs.132415AxeELAutophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum20081826857011:CAS:528:DC%2BD1cXhtV2rurzK18725538251870810.1083/jcb.200803137MizushimaNThe ATG conjugation systems in autophagy2019631103190164510.1016/j.ceb.2019.12.0011:CAS:528:DC%2BB3cXjt1Onsg%3D%3DItakuraEKishi-ItakuraCMizushimaNThe hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes2012151125612691:CAS:528:DC%2BC38XhvVaisrvK2321770910.1016/j.cell.2012.11.001RavikumarBMammalian macroautophagy at a glance2009122170717111:CAS:528:DC%2BD1MXosVCntrY%3D19461070268483010.1242/jcs.031773SaxtonRASabatiniDMmTOR signaling in growth, metabolism, and disease20171689609761:CAS:528:DC%2BC2sXkt1Ogtb4%3D28283069539498710.1016/j.cell.2017.02.004Aksnes, H., Hole, K. & Arnesen, T. in International Review of Cell and Molecular Biology, Vol 316 Vol. 316 International Review of Cell and Molecular Biology (ed. K. W. Jeon) 267–305 (2015).StarheimKKGevaertKArnesenTProtein N-terminal acetyltransferases: when the start matters2012371521611:CAS:528:DC%2BC38XjsFOntL4%3D2240557210.1016/j.tibs.2012.02.003ChoudharyCWeinertBTNishidaYVerdinEMannMThe growing landscape of lysine acetylation links metabolism and cell signalling2014155365501:CAS:528:DC%2BC2cXhtF2ktbrN2505335910.1038/nrm3841NaritaTWeinertBTChoudharyCFunctions and mechanisms of non-histone protein acetylation2019201561741:CAS:528:DC%2BC1MXns1Gmt7s%3D3046742710.1038/s41580-018-0081-3PougovkinaOMitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation201423351335221:CAS:528:DC%2BC2cXpvV2rs7s%3D2451607110.1093/hmg/ddu059DaviesMNThe acetyl group buffering action of carnitine acetyltransferase offsets macronutrient-induced lysine acetylation of mitochondrial proteins2016142432541:CAS:528:DC%2BC28XhvFaruw%3D%3D2674870610.1016/j.celrep.2015.12.030SheikhBNAkhtarAThe many lives of KATs - detectors, integrators and modulators of the cellular environment2019207231:CAS:528:DC%2BC1cXitV2qu73K3039004910.1038/s41576-018-0072-4SonSMLeucine signals to mTORC1 via its metabolite acetyl-coenzyme A201929192201 e1971:CAS:528:DC%2BC1cXhs1Kkt7nN30197302633133910.1016/j.cmet.2018.08.013KoriYProteome-wide acetylation dynamics in human cells2017728860605557904910.1038/s41598-017-09918-31:CAS:528:DC%2BC1cXhtlGhu7bPHaberlandMMontgomeryRLOlsonENThe many roles of histone deacetylases in development and physiology: implications for disease and therapy20091032421:CAS:528:DC%2BD1cXhsFWis7bI19065135321508810.1038/nrg2485HoutkooperRHPirinenEAuwerxJSirtuins as regulators of metabolism and healthspan2012132252381:CAS:528:DC%2BC38XjtlOktbw%3D22395773487280510.1038/nrm3293BanretiASassMGrabaYThe emerging role of acetylation in the regulation of autophagy201398198291:CAS:528:DC%2BC3sXhvVOnsr7L23466676367229310.4161/auto.23908LeeIHFinkelTRegulation of autophagy by the p300 acetyltransferase2009284632263281:CAS:528:DC%2BD1MXisVSkurk%3D19124466540532210.1074/jbc.M807135200HuangRDeacetylation of nuclear LC3 drives autophagy initiation under starvation2015574564661:CAS:528:DC%2BC2MXhtF2mtr0%3D256017542560175410.1016/j.molcel.2014.12.013SonSMLeucine regulates autophagy via acetylation of the mTORC1 component raptor2020111:CAS:528:DC%2BB3cXht1Cjsr7E32561715730510510.1038/s41467-020-16886-2Wang, Y. et al. Acetyltransferase GCN5 regulates autophagy and lysosome biogenesis by targeting TFEB. EMBO Rep., e48335, https://doi.org/10.15252/embr.201948335 (2019).JiaYLP300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy201671:CAS:528:DC%2BC28Xhs1Ggu7bL27711074513395910.1038/cddis.2016.247LinSYGSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy20123364774811:CAS:528:DC%2BC38XlvFGqsbg%3D2253972310.1126/science.121703222539723FullgrabeJThe histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy201350046847123863932400610310.1038/nature123131:CAS:528:DC%2BC3sXhtFWrsL%2FKKoenekeEWittOOehmeIHDAC family members intertwined in the regulation of autophagy: a druggable vulnerability in aggressive tumor entities201541351681:CAS:528:DC%2BC1cXlsVKitbY%3D25915736449345310.3390/cells4020135OhMChoiIKKwonHJInhibition of histone deacetylase1 induces autophagy2008369117911831:CAS:528:DC%2BD1cXksVeis7g%3D1834262110.1016/j.bbrc.2008.03.019CaoDJHistone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy2011108412341281:CAS:528:DC%2BC3MXjs1Wqtbc%3D2136769310.1073/pnas.101508110821367693MoresiVHistone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice2012109164916541:CAS:528:DC%2BC38XitlKltr4%3D2230762510.1073/pnas.1121159109KangZHHistone deacetylase HDAC4 promotes gastric cancer SGC-7901 cells progression via p21 repression2014924896240404586010.1371/journal.pone.00988941:CAS:528:DC%2BC2cXhsVGqsr%2FIRoccaroAMmicroRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia2010116150615141:CAS:528:DC%2BC3cXhtF2qsbzN20519629293884010.1182/blood-2010-01-265686HrzenjakASAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway20082164955041:CAS:528:DC%2BD1MXlvVWqsA%3D%3D1885058210.1002/path.2434Chiu, C. F. et al. Induction of apoptosis and autophagy in breast cancer cells by a novel HDAC8 inhibitor. Biomolecules9, https://doi.org/10.3390/biom9120824 (2019).ZhangZIncrease in HDAC9 suppresses myoblast differentiation via epigenetic regulation of autophagy in hypoxia2019101:CAS:528:DC%2BC1MXhs1KitrzK31320610663933010.1038/s41419-019-1763-2PandeyUBHDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS20074478598631:CAS:528:DC%2BD2sXms1WjsL8%3D1756874710.1038/nature0585317568747JungKHHistone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer2012566446571:CAS:528:DC%2BC38XhtVylu73J2239272810.1002/hep.25699LiuKPLC3B-II deacetylation by histone deacetylase 6 is involved in serum-starvation-induced autophagic degradation20134419709751:CAS:528:DC%2BC3sXhslyqu7%2FI2422033510.1016/j.bbrc.2013.11.00724220335LeeJYHDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy2010299699801:CAS:528:DC%2BC3cXhvFGisg%3D%3D20075865283716910.1038/emboj.2009.405OehmeIHistone deacetylase 10 promotes autophagy-mediated cell survival2013110E2592E26011:CAS:528:DC%2BC3sXht1Gls7vO2380175210.1073/pnas.130011311023801752LeeIHA role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy2008105337433791:CAS:528:DC%2BD1cXjtlKkt78%3D1829664110.1073/pnas.0712145105HariharanNDeacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes2010107147014821:CAS:528:DC%2BC3cXhsFChsb%2FN20947830301198610.1161/CIRCRESAHA.110.227371ZhaoYCytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity2010126656751:CAS:528:DC%2BC3cXot1Wmtbc%3D2054384010.1038/ncb2069MukherjeeSEffects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action201088101710251:CAS:528:DC%2BC3cXhtlahu73E10.1139/Y10-082ShiLSIRT5-mediated deacetylation of LDHB promotes autophagy and tumorigenesis in colorectal cancer2019133583751:CAS:528:DC%2BC1MXnt1elu7o%3D3044397810.1002/1878-0261.12408IachettiniSPharmacological activation of SIRT6 triggers lethal autophagy in human cancer cells2018930250025615520710.1038/s41419-018-1065-01:CAS:528:DC%2BC1cXhslymt7jJLangASIRT4 interacts with OPA1 and regulates mitochondrial quality control and mitophagy20179216321891:CAS:528:DC%2BC1MXhtlCqt7o%3D29081403568056110.18632/aging.101307DingMSIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer202039281:CAS:528:DC%2BB3cXkvVWks7g%3D32019578699810610.1186/s13046-019-1516-1GallardoGHoltzmanDMAmyloid-beta and Tau at the crossroads of Alzheimer’s disease201911841872031:CAS:528:DC%2BB3cXis1amsr%2FN3209603910.1007/978-981-32-9358-8_16RossOAGenomic investigation of alpha-synuclein multiplication and parkinsonism2008637437501:CAS:528:DC%2BD1cXptFegur0%3D1857177810.1002/ana.21380Shatunov, A. & Al-Chalabi, A. The genetic architecture of ALS. Neurobiol. Dis., 105156, https://doi.org/10.1016/j.nbd.2020.105156 (2020).RavikumarBDudenRRubinszteinDCAggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy200211110711171:CAS:528:DC%2BD38XjvFSntbo%3D1197876910.1093/hmg/11.9.1107RavikumarBInhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease2004365855951:CAS:528:DC%2BD2cXksVajt7s%3D1514618410.1038/ng1362WebbJLRavikumarBAtkinsJSkepperJNRubinszteinDCAlpha-Synuclein is degraded by both autophagy and the proteasome200327825009250131:CAS:528:DC%2BD3sXltVSlsbs%3D1271943310.1074/jbc.M300227200LopezAA152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction20171401128114628334843538295010.1093/brain/awx005SarkarSSmall molecules enhance autophagy and reduce toxicity in Huntington’s disease models200733313381:CAS:528:DC%2BD2sXltlOjurY%3D17486044263556110.1038/nchembio883WilliamsANovel targets for Huntington’s disease in an mTOR-independent autophagy pathway200842953051:CAS:528:DC%2BD1cXkvVSmt7c%3D18391949263556610.1038/nchembio.79MenziesFMAutophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 32010133931042000721810.1093/brain/awp2921:CAS:528:DC%2BC3cXot1ehsbo%3DRoseCRilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington’s disease201019214421531:CAS:528:DC%2BC3cXlvVWkt7o%3D20190273286537310.1093/hmg/ddq093SiddiqiFHFelodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing20191031000720647239010.1038/s41467-019-09494-21:CAS:528:DC%2BC1MXoslKlsr8%3DMenziesFMAutophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities201793101510341:CAS:528:DC%2BC2sXktVylur0%3D10.1016/j.neuron.2017.01.022RavikumarBBergerZVacherCO’KaneCJRubinszteinDCRapamycin pre-treatment protects against apoptosis200615120912161:CAS:528:DC%2BD28Xis1Shs70%3D1649772110.1093/hmg/ddl036RubinszteinDCBentoCFDereticVTherapeutic targeting of autophagy in neurodegenerative and infectious diseases20152129799901:CAS:528:DC%2BC2MXhtFymu7rN26101267449341910.1084/jem.20150956PesericoASimoneCPhysical and functional HAT/HDAC interplay regulates protein acetylation balance201120113718322115161310.1155/2011/3718321:CAS:528:DC%2BC3cXhsFOgtrzESahaRNPahanKHATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis2006135395501:CAS:528:DC%2BD28XitlKmsr4%3D16167067196341610.1038/sj.cdd.4401769LuXHistone acetyltransferase p300 mediates histone acetylation of PS1 and BACE1 in a cellular model of Alzheimer’s disease2014925051175410688610.1371/journal.pone.01030671:CAS:528:DC%2BC2cXhs1ersrvFCaccamoAMaldonadoMABokovAFMajumderSOddoSCBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer’s disease201010722687226921:CAS:528:DC%2BC3MXktlektA%3D%3D2114971210.1073/pnas.1012851108IrwinDJAcetylated tau, a novel pathological signature in Alzheimer’s disease and other tauopathies201213580781822366796328633810.1093/brain/aws013ChenXPromoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy20201521:CAS:528:DC%2BB3cXjslyrsw%3D%3D31906970694552210.1186/s13024-019-0354-0DuclotFMeffreJJacquetCGongoraCMauriceTMice knock out for the histone acetyltransferase p300/CREB binding protein-associated factor develop a resistance to amyloid toxicity20101678508631:CAS:528:DC%2BC3cXks1Wmu7g%3D2021964910.1016/j.neuroscience.2010.02.055PanikkerPRestoring Tip60 HAT/HDAC2 balance in the neurodegenerative brain relieves epigenetic transcriptional repression and reinstates cognition201838456945831:CAS:528:DC%2BC1cXhvVemur3N29654189594398210.1523/JNEUROSCI.2840-17.2018KimDDeregulation of HDAC1 by p25/Cdk5 in neurotoxicity2008608038171:CAS:528:DC%2BD1cXhsFahs7rE19081376291214710.1016/j.neuron.2008.10.015JanczuraKJInhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model2018115E11148E111571:CAS:528:DC%2BC1cXit1CrtrrP3039713210.1073/pnas.1805436115SenANelsonTJAlkonDLApoE4 and Abeta oligomers reduce BDNF expression via HDAC nuclear translocation201535753875511:CAS:528:DC%2BC2MXhtVCrsbjK25972179670543110.1523/JNEUROSCI.0260-15.2015DingHDolanPJJohnsonGVHistone deacetylase 6 interacts with the microtubule-associated protein tau2008106211921301:CAS:528:DC%2BD1cXhtV2rt7fM18636984257457510.1111/j.1471-4159.2008.05564.xGovindarajanNReducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer’s disease2013552631:CAS:528:DC%2BC3sXntFeh2318460510.1002/emmm.201201923JeskoHWencelPStrosznajderRPStrosznajderJBSirtuins and their roles in brain aging and neurodegenerative disorders2017428768901:CAS:528:DC%2BC28XhvFCisLrI2788244810.1007/s11064-016-2110-yKontopoulosEParvinJDFeanyMBAlpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity200615301230231:CAS:528:DC%2BD28XhtVOgt77L1695979510.1093/hmg/ddl243OuteiroTFSirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease20073175165191:CAS:528:DC%2BD2sXotFylurs%3D1758890010.1126/science.1143780SuzukiKKoikeTMammalian Sir2-related protein (SIRT) 2-mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation20071475996121:CAS:528:DC%2BD2sXntFygt7Y%3D1757476810.1016/j.neuroscience.2007.04.059DonmezGSIRT1 protects against alpha-synuclein aggregation by activating molecular chaperones2012321241321:CAS:528:DC%2BC38XovV2nuw%3D%3D22219275326320610.1523/JNEUROSCI.3442-11.2012BonnaudEMSuberbielleEMalnouCEHistone acetylation in neuronal (dys)function201671031161:CAS:528:DC%2BC28XnvVCqtb8%3D2710155410.1515/bmc-2016-0002McCampbellACREB-binding protein sequestration by expanded polyglutamine20009219722021:CAS:528:DC%2BD3cXmsFKiu78%3D1095865910.1093/hmg/9.14.2197GiampaCPhosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington’s disease2009299029101929122110.1111/j.1460-9568.2009.06649.xJiangHNuciforaFCJr.RossCADeFrancoDBCell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein2003121121249052710.1093/hmg/ddg002ChoiYJSuppression of aggregate formation of mutant huntingtin potentiates CREB-binding protein sequestration and apoptotic cell death2012491271371:CAS:528:DC%2BC38XitFOks7s%3D2212282410.1016/j.mcn.2011.11.003JeongHAcetylation targets mutant huntingtin to autophagosomes for degradation200913760721:CAS:528:DC%2BD1MXls1Srsrs%3D19345187294010810.1016/j.cell.2009.03.018JiangMNeuroprotective role of Sirt1 in mammalian models of Huntington’s disease through activation of multiple Sirt1 targets20111815315822179319455145310.1038/nm.25581:CAS:528:DC%2BC3MXhs1eitr%2FLNaiaLRegoACSirtuins: double players in Huntington’s disease20151852218321941:CAS:528:DC%2BC2MXhtFKis7zF2616399510.1016/j.bbadis.2015.07.003RouauxCCritical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration200322653765491:CAS:528:DC%2BD3sXpvVemtrg%3D1465702629181010.1093/emboj/cdg615JiangYMGene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis2005572362511:CAS:528:DC%2BD2MXhs1Cisbg%3D1566897610.1002/ana.20379De VosKJFamilial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content2007162720272817725983451680610.1093/hmg/ddm2261:CAS:528:DC%2BD2sXht1aksbjFCreppeCElongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin20091365515641:CAS:528:DC%2BD1MXltFSns78%3D1918533710.1016/j.cell.2008.11.043TaesIHdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS201322178317901:CAS:528:DC%2BC3sXlsVCjt7c%3D2336404910.1093/hmg/ddt028GalJHDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation201328815035150451:CAS:528:DC%2BC3sXot1WjtLc%3D23580651366352410.1074/jbc.M112.431957KimSHShanwareNPBowlerMJTibbettsRSAmyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA201028534097341051:CAS:528:DC%2BC3cXhtlWktrnF20720006296250810.1074/jbc.M110.154831BarbosaLFIncreased SOD1 association with chromatin, DNA damage, p53 activation, and apoptosis in a cellular model of SOD1-linked ALS201018024624711:CAS:528:DC%2BC3cXjt1Gqtb4%3D2009728510.1016/j.bbadis.2010.01.011PearsonMPML regulates p53 acetylation and premature senescence induced by oncogenic Ras20004062072101:CAS:528:DC%2BD3cXlsVWgt7k%3D1091036410.1038/35018127AubrySAssembly and interrogation of Alzheimer’s disease genetic networks reveal novel regulators of progression20151025781952436367110.1371/journal.pone.01203521:CAS:528:DC%2BC28XhsFSgu7w%3DSchuellerEDysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer’s disease patients2020331011161:CAS:528:DC%2BB3cXisV2isLY%3D3205759110.1016/j.euroneuro.2020.01.015PiroozniaSKTip60 HAT activity mediates APP induced lethality and apoptotic cell death in the CNS of a Drosophila Alzheimer’s disease model201271:CAS:528:DC%2BC38XhtFeisr%2FM22848598340610110.1371/journal.pone.0041776GuanJSHDAC2 negatively regulates memory formation and synaptic plasticity200945955601:CAS:528:DC%2BD1MXlsF2ltro%3D19424149349895810.1038/nature07925MahadyLFrontal cortex epigenetic dysregulation during the progression of Alzheimer’s disease2018621151311:CAS:528:DC%2BC1cXitl2lsLs%3D2943935610.3233/JAD-171032JulienCSirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease20096848581:CAS:528:DC%2BD1MXhsFGlsrg%3D19104446281357010.1097/NEN.0b013e3181922348GiraltALong-term memory deficits in Huntington’s disease are associated with reduced CBP histone acetylase activity201221120312161:CAS:528:DC%2BC38XivVeju78%3D2211693710.1093/hmg/ddr552BodaiLPallosJThompsonLMMarshJLPcaf modulates polyglutamine pathology in a Drosophila model of Huntington’s disease201291041061:CAS:528:DC%2BC38XhvFagtrk%3D2191209110.1159/000330505IwataARileyBEJohnstonJAKopitoRRHDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin200528040282402921:CAS:528:DC%2BD2MXht1Gjs7vM1619227110.1074/jbc.M508786200JeongHSirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway2011181591652217931610.1038/nm.25591:CAS:528:DC%2BC3MXhs1eisb3MLuthi-CarterRSIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis2010107792779321:CAS:528:DC%2BC3cXlsFymur0%3D2037883810.1073/pnas.1002924107JanssenCDifferential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis2010695735811:CAS:528:DC%2BC3cXmslWhtr8%3D2046733410.1097/NEN.0b013e3181ddd404FieselFCKnockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 62010292092211:CAS:528:DC%2BD1MXhtlKmsL3E1991092410.1038/emboj.2009.324
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.